Summary of guidance on aTIV published

Summary of guidance on aTIV published

September 17, 2018

In light of this year’s recommendations on the different types of flu vaccines for the Flu Vaccination Service 2018/19, PSNC has received many queries from contractors relating to the ordering and appropriate use of the adjuvanted trivalent influenza vaccine (aTIV).

PSNC has therefore published a Briefing which summarises the different documents and news stories relating to the use of aTIV that have been published by NHS England, Public Health England and PSNC.

The Briefing also explains what pharmacy contractors should do if they have no aTIV available, either temporarily or because they have been unable to obtain any aTIV for the 2018/19 flu season.

PSNC Briefing 050/18: Flu Vaccination Service 2018/19: Adjuvanted trivalent inactivated influenza vaccine (aTIV)

Further information, resources and answers frequently asked questions are available at

Posted in: , , ,

More Latest News >